We are live on ! Find out more
1CM

1492 Capital Management Portfolio holdings

AUM $263M
1-Year Est. Return 61.9%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$113M
AUM Growth
-$317K
Cap. Flow
-$7.98M
Cap. Flow %
-7.05%
Top 10 Hldgs %
34.22%
Holding
109
New
10
Increased
13
Reduced
67
Closed
17

Sector Composition

Rank Sector Weight
1 Technology 26.6%
2 Healthcare 19.8%
3 Industrials 12.13%
4 Consumer Discretionary 8.55%
5 Financials 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIMO icon
101
Silicon Motion
SIMO
$7.11B
-4,310
Closed -$208K
SM icon
102
SM Energy
SM
$7.6B
-18,639
Closed -$308K
SAVE
103
DELISTED
Spirit Airlines, Inc.
SAVE
-42,847
Closed -$2.21M
AUTO
104
DELISTED
AutoWeb, Inc. Common Stock
AUTO
-85,955
Closed -$1.08M
HABT
105
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
-21,067
Closed -$333K
WAGE
106
DELISTED
WageWorks, Inc.
WAGE
-19,819
Closed -$1.33M
EGN
107
DELISTED
Energen
EGN
-4,142
Closed -$204K
KITE
108
DELISTED
Kite Pharma, Inc.
KITE
-5,586
Closed -$579K
SWFT
109
DELISTED
Swift Transportation Company
SWFT
-112,629
Closed -$2.98M

Similar funds

1492 Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, 1492 Capital Management held 109 positions worth $113M, down 0.28% from $113M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

1492 Capital Management withdrew a net $7.98M in Q3 2017, closing 17 positions and reducing 67 holdings. Its most notable exit was Swift Transportation Company, an estimated $2.98M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, 1492 Capital Management opened a new position in Corcept Therapeutics worth $1.35M.

  • 1492 Capital Management's largest Q3 2017 buy was Corcept Therapeutics: 70,034 shares worth $1.35M.
  • 1492 Capital Management added most to Evolent Health in Q3 2017, an estimated $1.67M increase.
  • 1492 Capital Management's biggest Q3 2017 reduction was Matador Resources, cutting an estimated $708K.
  • 1492 Capital Management fully exited Swift Transportation Company in Q3 2017, selling an estimated $2.98M.
  • 1492 Capital Management's ten largest holdings make up 34% of its $113M portfolio in Q3 2017.
  • 1492 Capital Management opened 10 new positions and closed 17 in Q3 2017.
  • 1492 Capital Management's portfolio value fell 0.28% quarter-over-quarter to $113M.

Based on 1492 Capital Management's 13F filing for Q3 2017, filed 9 Nov 2017.